跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,132 条关于
“HZN-825 BID”
全部
10,132
临床试验
6,543
药物
1,929
机构
280
资讯
1,380
去年
Systemic Sclerosis Pipeline Shows Promise with 50+ Therapies in Development
去年
Kriya Therapeutics Presents Promising Preclinical Data for KRIYA-825 Gene Therapy in Geographic Atrophy
11个月前
Beta Technologies Files for $825 Million IPO to Fund Electric Aircraft Development
去年
Boundless Bio Prioritizes BBI-355 and New ecDTx Program, Discontinues BBI-825 Development
去年
JCR Pharmaceuticals Licenses JUST-AAV Gene Therapy Platform to Alexion in $825 Million Deal
3个月前
PDS Biotechnology Regains Nasdaq Compliance After Minimum Bid Price Deficiency
去年
NeuroSense Therapeutics Regains Compliance with NASDAQ, Plans Phase 3 Trial for PrimeC
2年前
NeuroSense Therapeutics Regains NASDAQ Compliance After Positive PrimeC Trial Data
去年
FDA Delays Approval of J&J's Subcutaneous Rybrevant for Lung Cancer Treatment
2个月前
Repeated High-Voltage Pulsed Radiofrequency Reduces Postherpetic Neuralgia Incidence in Diabetic Patients with Thoracic Herpes Zoster
第 1 页,共 138 页
上一页
下一页